Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Cartherics for InfoPages here.
Cartherics - Latest News [Page 1]
Cartherics Raises Over $15 Million In Oversubscribed Private Financing Round To Advance Cell Therapy Programs
Tuesday, 1 October 2024, 5:35 pm | Cartherics
This funding will support the initiation of the clinical trial for CTH-401, the Company’s lead cell therapy product, aimed at treating ovarian cancer, as well as broadening its pipeline to include other disease indications. More >>
Cartherics Enters Agreements With Uniquest, UQ & USYD For Advancing Innovative Cardiac Cellular Therapy
Thursday, 25 July 2024, 2:03 pm | Cartherics
In parallel, Cartherics, The University of Queensland (“UQ”) and The University of Sydney have entered into a related Material Transfer Agreement (MTA). More >>
Cartherics Secures Australian Patent For Innovative Cancer Cell Therapy
Wednesday, 12 June 2024, 6:29 pm | Cartherics
This patent enhances Cartherics’ expanding intellectual property portfolio and covers aspects of the Company’s chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72. More >>
Cartherics Enters Into Collaborative Research Agreement With TiCARos
Wednesday, 3 April 2024, 7:56 am | Cartherics
Melbourne, Australia, 2 April 2024 – Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has entered a collaborative research agreement with ... More >>
Positive Pre-IND Meeting With US FDA For New Ovarian Cancer Cell Therapy
Thursday, 1 February 2024, 6:54 pm | Cartherics
Melbourne, Australia, 1 February 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has successfully completed a ... More >>
